Securities code: 300981 securities abbreviation: Zhonghong Pulin Medical Products Co.Ltd(300981) Announcement No.: 2022-007 Zhonghong Pulin Medical Products Co.Ltd(300981)
Announcement on the company and its subsidiaries applying to the bank for comprehensive credit line in 2022 and the company providing guarantee for subsidiaries applying for comprehensive credit line
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Overview of credit and guarantee
Zhonghong Pulin Medical Products Co.Ltd(300981) (hereinafter referred to as “the company”) held the seventh meeting of the third board of directors and the sixth meeting of the third board of supervisors on February 23, 2022, and deliberated and adopted the proposal on the application of the company and its subsidiaries to the bank for comprehensive credit line in 2022 and the guarantee provided by the company for its subsidiaries to apply for comprehensive credit line, Among them, it is agreed that the total amount of comprehensive credit lines applied by the company and its subsidiaries to relevant banks in 2022 shall not exceed 4 billion yuan, and the final credit line shall be subject to the credit line actually approved by each bank. Among them, the total amount of credit lines applied to the above financial institutions by means of self owned assets mortgage and pledge shall not exceed 1 billion yuan, and each mortgage and pledge subject can be used within the scope of the total mortgage and pledge line; Among them, in 2022, the company’s wholly-owned subsidiary Jiangxi zhonghongprin Medical Products Co., Ltd. (hereinafter referred to as “Jiangxi Zhonghong”) plans to apply for some comprehensive credit lines from relevant banks, and the company will provide a guarantee with a total amount of no more than 1 billion yuan to relevant banks.
In order to facilitate the implementation of the above application for credit and guarantee from the bank, the general meeting of shareholders is requested to authorize the company and Jiangxi Zhonghong to determine the specific credit and guarantee matters such as the credit subject, the mortgage and pledge subject, the selection of financial institutions and the specific variety, amount and term used in the application for credit line within the above credit line and guarantee line, The legal representative of the company or its designated agent and the legal representative of Jiangxi Zhonghong are authorized to sign relevant legal documents within the limit and handle relevant matters on behalf of the company. The signing period is from the date of deliberation and approval by the general meeting of shareholders to December 31, 2022.
The proposal needs to be submitted to the general meeting of shareholders for deliberation and approved by more than two-thirds of the voting rights held by the shareholders attending the meeting.
The estimated guarantee amount of the company and its wholly-owned subsidiaries is as follows:
Expected new
Up to now, whether the guaranteed party’s estimated guarantee amount is the guarantor? The guaranteed party’s guarantor holds the guarantee balance of the latest period, the proportion of new guarantee in the related proportion of listed companies, asset liability (10000 yuan) line (10000 company’s latest guarantee rate of yuan) net assets of the current period
proportion
Zhonghongpu, Jiangxi zhonghongpu
Medical supplies Lin medical products 100% 56.37% 15000 100000 15.32% no Co., Ltd
Note: 1 The latest period in the above table refers to the unaudited financial data as of September 30, 2021;
2. The asset liability ratio of the guaranteed party does not exceed 70%.
2、 Basic information of the guaranteed company
Company name: Jiangxi zhonghongprin Medical Products Co., Ltd
Legal representative: Chen Jun
Registered capital: RMB 50 million
Date of establishment: October 30, 2017
Company type: limited liability company (sole proprietorship of legal person invested or controlled by non natural person)
Registered address: yinshawan Park, high tech Industrial Park, Hukou County, Jiujiang City, Jiangxi Province
Business scope: production of PVC gloves, nitrile gloves, PE, latex series products, plastic cups, plastic bags and other plastic products, packaging products, wholesale of class I medical devices, transportation of ordinary goods, self support and agency of import and export of various commodities and technologies (except for goods and technologies whose import and export are restricted or prohibited by the state). (for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments)
Relationship with the company: the company holds 100% equity of Jiangxi Zhonghong.
Financial situation: (1) as of December 31, 2020 (audited), Jiangxi Zhonghong has total assets of 919.17 million yuan, total liabilities of 521.48 million yuan and net assets of 397.69 million yuan. The operating income is 766.08 million yuan, the total profit is 468.37 million yuan, and the net profit is 351.23 million yuan; (2) As of September 30, 2021, Jiangxi Zhonghong has total assets of 1390.46 million yuan, total liabilities of 783.88 million yuan, net assets of 606.58 million yuan, operating income of 532.83 million yuan, total profit of 285.5 million yuan and net profit of 208.88 million yuan.
After verification, Jiangxi Zhonghong is not a dishonest person to be executed, and it has the ability to repay debts.
3、 Main contents of guarantee agreement
The company and its wholly-owned subsidiaries have not yet signed the relevant credit agreement and guarantee agreement with the above-mentioned banks. The company and its wholly-owned subsidiaries will sign the bank loan according to the actual capital demand. The specific credit and guarantee amount shall be subject to the actually signed contract, and the final actual guarantee amount will not exceed the guarantee limit deliberated and approved at this meeting. 4、 Review procedure
1. Opinions of the board of directors
On February 23, 2022, the seventh meeting of the third board of directors of the company, with the consent of more than two-thirds of the directors attending the meeting of the board of directors, deliberated and adopted the proposal on the application of comprehensive credit line by the company and its subsidiaries to the bank in 2022 and the provision of guarantee for the application of comprehensive credit line by the company for its subsidiaries, and agreed that the company should implement the above contents, It needs to be submitted to the general meeting of shareholders for deliberation and approval.
2. Opinions of independent directors
The independent directors believe that the credit line applied for this time is within the scope of the daily needs of the company’s production and operation. The guaranteed objects involved in the guarantee are the company and its holding subsidiaries. Its business activities are uniformly managed by the company and the business risk is controllable. The above guarantee behavior belongs to the normal business activities of the company, and the guarantee will not damage the interests of the company. Agree that the company and its holding subsidiaries apply for credit lines and guarantees from banks and other financial institutions, and agree to submit them to the general meeting of shareholders for deliberation.
3. Opinions of the board of supervisors
On February 23, 2022, the sixth meeting of the third session of the board of supervisors deliberated and adopted the proposal on the application of the company and its subsidiaries to the bank for comprehensive credit line in 2022 and the guarantee provided by the company for the subsidiary’s application for comprehensive credit line. The board of supervisors agreed that the above credit and guarantee matters need to be submitted to the general meeting of shareholders for deliberation and approval. 5、 Accumulated external guarantees and overdue guarantees
As of the date of this announcement, the total amount of guarantee of the company and its holding subsidiaries is 150 million yuan, accounting for 5.87% of the net assets of the company’s latest audited consolidated statements (2020 financial statements). The company and its holding subsidiaries do not provide guarantees for entities outside the scope of the consolidated statements, and there are no overdue guarantees or guarantees involving litigation.
6、 Documents for future reference
1. Resolutions of the seventh meeting of the third board of directors of the company;
2. Resolutions of the sixth meeting of the third board of supervisors of the company;
3. Independent opinions of independent directors on matters related to the seventh meeting of the third board of directors. It is hereby announced.
Zhonghong Pulin Medical Products Co.Ltd(300981) board of directors February 23, 2002
